timebase0
About
Interferon-gamma launch analysis assessment to assess COVID-19 vaccine reaction in a SARS-CoV-2 seronegative affected individual on rituximab: in a situation statement.
Interferon-gamma launch analysis assessment to assess COVID-19 vaccine reaction in a SARS-CoV-2 seronegative affected individual on rituximab: in a situation statement.